Diwakar Chada is a seasoned finance professional with extensive experience in investment management and analysis. Currently serving as Managing Director at Azalea Investment Management since April 2022, Chada previously held the position of Director at Temasek Holdings from September 2012 to March 2022. Prior roles include Investment Associate at SVG Advisers, where responsibilities included the analysis and due diligence of Private Equity fund managers in Asia, and Scientific Associate at Novartis, contributing to drug discovery efforts and scientific due diligence. Chada holds an MBA in Finance from Nanyang Technological University Singapore, a Master of Science in Chemical Engineering from the University of Oklahoma, and a Bachelor of Technology in Chemical Engineering from the Indian Institute of Technology, Madras.
This person is not in any teams
This person is not in any offices
Azalea Investment Management
1 followers
Set up in 2015, Azalea is a wholly-owned subsidiary of Seviora, and indirectly owned by Temasek Holdings (Private) Limited. Azalea is in the business of investing in private equity (“PE”), with a focus on the development and innovation of new investment platforms and products. Its goal is to bring private assets to a wider investor base through a phased approach, starting with PE. It is also committed to educating the investing public. Starting with Astrea IV, the Astrea platform has placed these listed bonds into the hands of retail investors in Singapore, allowing them to use these PE bonds to diversify their portfolios. In 2019, the first Altrium PE fund of funds was launched, allowing local accredited investors access to high quality private equity managers. Altrium was designed for wider participation by lowering the investment amount and holding period.